Accuray Reports Significantly Wider Losses, Declining Revenue, and Persistent Internal Control Weaknesses; Faces Nasdaq Delisting Threat

summarizeSummary

Accuray reported substantially wider net losses and declining revenue for Q3 FY26, detailed persistent material weaknesses in internal controls, and confirmed a Nasdaq delisting warning, highlighting severe financial and operational challenges.

check_boxKey Events

• Significant Financial Deterioration

  Net loss for Q3 FY26 widened to $(11.805) million from $(1.297) million in Q3 FY25, and year-to-date net loss reached $(47.253) million compared to $(2.714) million in the prior year. Total net revenue decreased 7% year-over-year for the quarter to $104.845 million, and 9% year-to-date to $301.028 million. Cash and cash equivalents declined by $19.349 million since June 30, 2025, to $38.067 million, with net cash used in operating activities of $(9.408) million for the nine months ended March 31, 2026, a significant reversal from positive cash flow in the prior year.

• Persistent Material Weaknesses in Internal Controls

  Management concluded that disclosure controls and procedures were not effective as of March 31, 2026, due to material weaknesses related to footnote disclosures and GAAP analysis. These weaknesses previously led to restatements of financial statements for fiscal year 2025 and several prior quarters, indicating ongoing risks to financial reporting accuracy.

• Nasdaq Delisting Warning

  The company received a notice on February 2, 2026, for non-compliance with Nasdaq's $1.00 minimum bid price rule, with a compliance period until August 3, 2026. Failure to regain compliance could result in delisting, severely impacting liquidity and access to capital.

• High-Cost Debt and Near-Term Maturity

  The weighted average effective interest rate on the Term Loan Facility increased to 24.5% (from 22.0% in June 2025), and the Revolving Credit Facility's rate is 20.5% (from 0.0%). The company has $18.0 million in Convertible Senior Notes due on June 1, 2026, which it intends to pay using proceeds from its Delayed Draw Facility.

auto_awesomeAnalysis

Accuray's detailed Q3 FY26 report confirms a severe deterioration in financial performance, with net losses widening dramatically and revenue declining. The company is grappling with high-cost debt, evidenced by a 24.5% effective interest rate on its Term Loan Facility and 20.5% on its Revolving Credit Facility, alongside a near-term maturity of $18.0 million in convertible notes. Critically, Accuray continues to report material weaknesses in its internal controls over financial reporting, a recurring issue that previously led to financial restatements and undermines investor confidence. The company also faces a Nasdaq delisting threat due to its stock price falling below the $1.00 minimum bid requirement, with a compliance deadline of August 3, 2026. These combined factors paint a highly negative picture of the company's operational and financial health, indicating significant challenges to its ongoing viability and ability to meet obligations.